Overview
Proposes a multilayered approach to medicinal product risk communication research for increasingly emerging collaborations between disciplines and parties aiming at understanding, planning and evaluating communication for improved health outcomes
Presents a wide range of research methods in accessible language, underpinned by overviews on communication types and outcomes in practical tables and illustrated by examples and case studies of real life experiences of safety concerns with medicines
Written by internationally experienced authors for a global readership of researchers, practitioners, students and patient advocates active in communications, healthcare, the social sciences and pharmacovigilance
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (16 chapters)
-
Front Matter
-
Medicines in Real Life as Communication Challenges
-
Front Matter
-
-
Tackling the Challenges: Methods for Medicinal Product Risk Communication Research
-
Front Matter
-
-
Back Matter
Keywords
About this book
At the core of this book lies the question how to approach medicines, risks and communication as a researcher - or anybody planning and evaluating a communication intervention, or wanting to understand communication events in private and the media. With a view to tackle current shortcomings of communication systems and processes for improved implementation, patient satisfaction and health outcomes, a multilayered approach is presented. This combines multiple data types and methods to obtain a wider and deeper understanding of the major parties and their interactions, as well as the healthcare, social and political contexts of information flows, how they interfere and which impact they have. Illustrated with real life experiences of safety concerns with medicines, worldwide active experts discuss the methods and contributions their disciplines can offer. With considerations on terminologies, tabulated overviews on communication types and outcomes, a patient-centred vision and plain language for non-medical readers, the book creates a platform for multidisciplinary collaborations amongst researchers as well as practitioners from communications, healthcare, the social sciences and pharmacovigilance. Importantly, it advocates for an active role of patients and highlights the achievements and aspirations of patient organisations. Finally, the book suggests establishing an inclusive discipline of humanities and epidemiology of medicinal product risk communication to realise full research potential. The authors are driven by the curiosity for communication as the most human behaviour, and as good health is amongst the basic human needs, medicinal product risk communication is an exciting research field of high global relevance.
Editors and Affiliations
About the editor
Bibliographic Information
Book Title: Communicating about Risks and Safe Use of Medicines
Book Subtitle: Real Life and Applied Research
Editors: Priya Bahri
DOI: https://doi.org/10.1007/978-981-15-3013-5
Publisher: Adis Singapore
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2020
Hardcover ISBN: 978-981-15-3012-8Published: 18 June 2020
eBook ISBN: 978-981-15-3013-5Published: 17 June 2020
Edition Number: 1
Number of Pages: XXX, 504
Number of Illustrations: 2 b/w illustrations, 30 illustrations in colour